Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

Cosmos Health, Inc. operates as a pharmaceutical company. The Company identifies, acquires, develops, and commercializes generic pharmaceuticals, nutraceuticals, OTC medications, and medical devices that improve patients lives and outcomes. Cosmos Health serves patients worldwide.

<ul><li>Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets.</li><li> Cosmos Health announced initial sales results from their recently introduced US subscription business.</li><li> Initial signs are extremely encouraging and show accelerating growth prospects.</li></ul>

Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets. Cosmos Health announced initial sales results from their recently introduced US subscription business. Initial signs are extremely encouraging and show accelerating growth prospects.

COSM: More Evidence of Accelerating Growth

New Horizon Aircraft Ltd. operates as an aerospace engineering company. The Company develops hybrid eVTOL that is to be able to fly most of its mission exactly like a normal aircraft while offering industry-leading speed, range, and operational utility. New Horizon Aircraft serves customers worldwide.

<ul><li>Horizon Aircraft released first-quarter results, which showed a marked increase in R&D spending (primarily related to engineering activities) as the company ramps up development of its full-scale demonstrator aircraft.</li><li> The company's balance sheet remains very strong, and it believes it has adequate cash to fund the next two years of operations.</li><li> The company continues to work on integrating several key systems to assemble its full-scale demonstrator within six months.</li></ul>

Horizon Aircraft released first-quarter results, which showed a marked increase in R&D spending (primarily related to engineering activities) as the company ramps up development of its full-scale demonstrator aircraft. The company's balance sheet remains very strong, and it believes it has adequate cash to fund the next two years of operations. The company continues to work on integrating several key systems to assemble its full-scale demonstrator within six months.

HOVR: Investing in the Full-Scale X7 Demonstrator While Navigating Choppy EVTOL Seas.

Horizon Aircraft released first-quarter results

Grupo Mexico Sab De Cv / Equity Bottom-Up

Grupo Mexico SAB de CV mines, processes, and markets copper, silver, gold, molybdenum, lead, and zinc.  The Company holds concessions to operate the Pacifico-Norte and Chihuahua-Pacifico Railroad lines.  Grupo Mexico, through subsidiaries, operates open-pit copper mines, underground mines, a coal mine, copper smelters, a rod mill facility, and a precious metals refinery.

<ul>
<li>GMEX's goal is to offer turnkey solutions that are easy to implement, operate and maintain.</li>
<li>As the company advances internal R&amp;D efforts to inform the design and development of robotics solutions, GMEX is expanding its technical workforce.</li>
<li>Recent innovations include integration of sensors &amp; connected systems to capture real-time movement and data to facilitate ML &amp; underpin a planned revenue stream based on AI and fleet-intelligence.</li>
</ul>


GMEX's goal is to offer turnkey solutions that are easy to implement, operate and maintain.
As the company advances internal R&amp;D efforts to inform the design and development of robotics solutions, GMEX is expanding its technical workforce.
Recent innovations include integration of sensors &amp; connected systems to capture real-time movement and data to facilitate ML &amp; underpin a planned revenue stream based on AI and fleet-intelligence.


GMEX: Emerging Robotics Strategy Deploying 1st Order & Building Pipeline - Initiating Coverage

AEON Biopharma, Inc. operates as a clinical stage biopharmaceutical company. The Company focuses on developing novel and proprietary treatment paradigms to improve patient outcomes of debilitating medical conditions. AEON Biopharma serves customers in the United States.

<ul><li>AEON Biopharma is a clinical-stage, specialty pharmaceutical company developing a Botox biosimilar.</li><li>In partnership with Daewoong, it is conducting analytical work to demonstrate biosimilarity for ABP-450.</li><li>Following a Type 2b meeting with the FDA, we expect 2027 PD & bridging studies to support the Section 351(k) BLA package for approval.</li></ul>

AEON Biopharma is a clinical-stage, specialty pharmaceutical company developing a Botox biosimilar.In partnership with Daewoong, it is conducting analytical work to demonstrate biosimilarity for ABP-450.Following a Type 2b meeting with the FDA, we expect 2027 PD & bridging studies to support the Section 351(k) BLA package for approval.

AEON: Initiating Coverage - Imitation is a Sincere Form of Flattery: Seeking a Botox Biosimilar